| 中文名 | 1-(2’-O,4-C-甲桥-beta-D-呋喃核糖基)胸腺嘧啶 |
|---|---|
| 英文名 | 1-(2'-O,4-C-Methylene-β-D-ribofuranosyl)thymine |
| 中文别名 |
1-(2'-O-4-C-亚甲桥基-BETA-D-呋喃核糖基)胸腺嘧啶
5-甲基-2'-O,4'-C-亚甲基尿苷 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶核苷 1-((1S,3R,4R,7S)-7-羟基-1-(羟甲基)-2,5-二氧杂双环[2.2.1]庚烷-3-基)-5-甲基嘧啶-2,4(1H,3H)-二酮 |
| 英文别名 |
5-Methyl-2'-O,4'-C-methyleneuridine
2'-O-4'-C-Locked-5-Me-rU (1S,3R,4R,7S)-7-hydroxy-1-hydroxymethyl-3-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane 2'-O,4'-C-methylene-5-methyluridine LNA-methyl-U (1S,3R,4R,7S)-7-hydroxy-1-hydroxymethyl-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane LNA-5MeU 2'-O,4'-C-methylenethymidine 2,4(1H,3H)-PYRIMIDINEDIONE, 1-[2,5-ANHYDRO-4-C-(HYDROXYMETHYL)-ALPHA-L-LYXOFURANOSYL]-5-METHYL 2,4(1H,3H)-Pyrimidinedione, 1-[2,5-anhydro-4-C-(hydroxymethyl)-α-L-lyxofuranosyl]-5-methyl- (9CI, ACI) 2'-O,4'-C-Methylene-5-Me-uridine 1-[2,5-Anhydro-4-C-(hydroxymethyl)-alpha-L-lyxofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione 5-Methyl-2’-O,4’-C-methyleneuridine 2,4(1H,3H)-Pyrimidinedione, 1-[2,5-anhydro-4-C-(hydroxymethyl)-α-L-lyxofuranosyl]-5-methyl 1-(2'-O,4-C-Methylene-beta-D-ribofuranosyl)thymine LNA-002 1-(2'-O, 4-C-Methylene-β-D- ribofuranosyl)thyMine 2'-O-4'-C-Locked-T 5-methyl-2'-O,4'-C-methyleneuridine 1-(2'-O-4-C-Methylene-b-D-ribofuranosyl)thymine 1-[(1S,3R,4R,7S)-7-Hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]htan-3-yl]-5-methylpyrimidine-2,4(1H,3H)-dione 5-Methyl-2’-O,4’-C-methyleneuridine, LNA-5MeU |
| 描述 | 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine 是一种双环核苷。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.598 |
|---|---|
| 分子式 | C11H14N2O6 |
| 分子量 | 270.23900 |
| 精确质量 | 270.08500 |
| PSA | 113.78000 |
| 上游产品 4 | |
|---|---|
| 下游产品 0 | |